(GALT) Galectin Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Galectin Therapeutics | (GALT) share price targets
Complete technical analysis of Galectin Therapeutics (GALT) by charts plus indicators, forecast predictions and share price targets for Galectin Therapeutics (GALT)
Galectin Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Galectin Therapeutics is 424090
| Date | Daily Closing Price | Open | High | Low | Volume |
| 18 Thu Apr 2024 | 3.38 | 3.37 | 3.45 | 3.25 | 0.346 times |
| 17 Wed Apr 2024 | 3.38 | 3.40 | 3.49 | 3.20 | 0.375 times |
| 16 Tue Apr 2024 | 3.40 | 3.87 | 3.87 | 3.32 | 0.827 times |
| 15 Mon Apr 2024 | 3.91 | 3.90 | 3.95 | 3.75 | 0.391 times |
| 12 Fri Apr 2024 | 3.97 | 4.25 | 4.27 | 3.75 | 1.16 times |
| 11 Thu Apr 2024 | 4.20 | 3.82 | 4.21 | 3.71 | 0.962 times |
| 10 Wed Apr 2024 | 3.82 | 3.91 | 4.10 | 3.66 | 1.526 times |
| 09 Tue Apr 2024 | 3.94 | 3.74 | 3.97 | 3.68 | 0.783 times |
| 08 Mon Apr 2024 | 3.74 | 3.66 | 3.75 | 3.40 | 1.107 times |
| 05 Fri Apr 2024 | 3.73 | 2.98 | 3.74 | 2.98 | 2.196 times |
My analysis of stock is bullish for shortterm, and stock might move up till 3.8 or till 4.6. Use a stoploss of 3.13 and if this stock hits its stoploss, then it can fall down till 2.47
Share price targets for Galectin Therapeutics (GALT)
| Target Type | Value |
| Downside Target | 1.56 |
| Downside Target | 1.63 |
| Downside Target | 1.90 |
| Downside Target | 2.00 |
| Downside Target | 2.07 |
| Downside Target | 2.26 |
| Downside Target | 2.48 |
| Downside Target | 3.20 |
| Upside Target | 3.40 |
| Upside Target | 3.74 |
| Upside Target | 3.95 |
| Upside Target | 4.27 |
Intraday share price targets for Galectin Therapeutics (GALT)
| Target Type | Value |
| Downside Intraday Target | 3.07 |
| Downside Intraday Target | 2.76 |
| Upside Intraday Target | 3.82 |
| Upside Intraday Target | 4.26 |
| Upside Intraday Target | 3.51 |
Weekly technical analysis of Galectin Therapeutics (GALT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 18 Thu Apr 2024 | 3.38 | 3.90 | 3.95 | 3.20 | 0.35 times |
| 12 Fri Apr 2024 | 3.97 | 3.66 | 4.27 | 3.40 | 1.279 times |
| 05 Fri Apr 2024 | 3.73 | 2.39 | 3.74 | 2.26 | 5.243 times |
| 28 Thu Mar 2024 | 2.39 | 2.44 | 2.48 | 2.27 | 0.461 times |
| 22 Fri Mar 2024 | 2.44 | 2.04 | 2.48 | 2.01 | 1.958 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Galectin Therapeutics (GALT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 18 Thu Apr 2024 | 3.38 | 2.39 | 4.27 | 2.26 | 2.438 times |
| 28 Thu Mar 2024 | 2.39 | 1.98 | 2.48 | 1.90 | 1.828 times |
| 29 Thu Feb 2024 | 1.96 | 1.70 | 2.00 | 1.59 | 0.9 times |
| 31 Wed Jan 2024 | 1.69 | 1.68 | 1.93 | 1.63 | 0.663 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Galectin Therapeutics (GALT)
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Galectin Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Galectin Therapeutics in short term but the sell signal is initial and weak.
Galectin Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Galectin Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Galectin Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.79 and Galectin Therapeutics (GALT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Galectin Therapeutics (GALT) stock. Volume based technical analysis of Galectin Therapeutics (GALT) stock is negative.
Galectin Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Galectin Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Galectin Therapeutics in short term but the sell signal is initial and weak.
Galectin Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Galectin Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Galectin Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.79 and Galectin Therapeutics (GALT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Galectin Therapeutics (GALT) stock. Volume based technical analysis of Galectin Therapeutics (GALT) stock is negative.
Galectin Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.